Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2021-08-13

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$824.4m reported value -10.6% vs Q1 2021
29positions
67.7%in top 10
9 new 2 added 6 reduced 8 sold out vs Q1 2021

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INSTIL BIO INC COM COM 6,865,076 $132.6m16.09% 16.09% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 6.9m, Q2 2021 6.9m
2 ACLARIS THERAPEUTICS INC COM ACRS ACRS 4,563,962 $80.1m9.72% 9.72% AddedShares held: Q3 2020 0, Q4 2020 2.0m, Q1 2021 3.7m, Q2 2021 4.6m +843.4k +843,380 22.7%
3 VISTAGEN THERAPEUTICS INC COM NEW VTGN VTGN 16,047,286 $50.5m6.13% 6.13% ReducedShares held: Q3 2020 0, Q4 2020 9.4m, Q1 2021 16.3m, Q2 2021 16.0m -255.3k -255,310 -1.6%
4 GRAPHITE BIO INC COM GRPH GRPH 1,612,617 $49.6m6.01% 6.01% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.6m
5 MARINUS PHARMACEUTICALS INC COM NEW MRNS MRNS 2,641,809 $47.4m5.75% 5.75% UnchangedShares held: Q3 2020 0, Q4 2020 2.6m, Q1 2021 2.6m, Q2 2021 2.6m
6 RELMADA THERAPEUTICS INC COM RLMD RLMD 1,387,720 $44.4m5.39% 5.39% AddedShares held: Q3 2020 668.4k, Q4 2020 668.4k, Q1 2021 853.2k, Q2 2021 1.4m +534.5k +534,514 62.6%
7 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 1,536,193 $43.0m5.21% 5.21% UnchangedShares held: Q3 2020 0, Q4 2020 1.5m, Q1 2021 1.5m, Q2 2021 1.5m
8 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 1,240,610 $41.5m5.03% 5.03% UnchangedShares held: Q3 2020 800.0k, Q4 2020 800.0k, Q1 2021 1.2m, Q2 2021 1.2m
9 ALTIMMUNE INC COM NEW ALT ALT 3,500,000 $34.5m4.18% 4.18% UnchangedShares held: Q3 2020 4.5m, Q4 2020 4.5m, Q1 2021 3.5m, Q2 2021 3.5m
10 KINNATE BIOPHARMA INC COM KNTE KNTE 1,473,014 $34.3m4.16% 4.16% UnchangedShares held: Q3 2020 0, Q4 2020 1.5m, Q1 2021 1.5m, Q2 2021 1.5m
11 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 1,275,831 $27.7m3.36% 3.36% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.3m
12 CULLINAN THERAPEUTICS INC COM CGEM CGEM 976,145 $25.1m3.05% 3.05% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.2m, Q2 2021 976.1k -200.0k -200,000 -17.0%
13 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 1,127,272 $25.0m3.04% 3.04% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.1m
14 PROVENTION BIO INC COM PRVB PRVB 2,902,744 $24.5m2.97% 2.97% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 2.9m
15 TRILLIUM THERAPEUTICS INC COM NEW TR TR 2,001,686 $19.4m2.36% 2.36% ReducedShares held: Q3 2020 7.2m, Q4 2020 4.0m, Q1 2021 4.0m, Q2 2021 2.0m -2.0m -2,038,314 -50.5%
16 ESSA PHARMA INC COM NEW EPI EPI 625,754 $17.9m2.17% 2.17% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 625.8k, Q2 2021 625.8k
17 CVRX INC COM CVRX CVRX 633,370 $17.7m2.15% 2.15% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 633.4k
18 PHARVARIS N V COM PHVS PHVS 902,882 $16.8m2.04% 2.04% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 902.9k, Q2 2021 902.9k
19 ATHIRA PHARMA INC COM COM 1,485,005 $15.2m1.84% 1.84% ReducedShares held: Q3 2020 1.5m, Q4 2020 1.7m, Q1 2021 1.7m, Q2 2021 1.5m -206.6k -206,618 -12.2%
20 RAPT THERAPEUTICS INC COM COM 391,000 $12.4m1.51% 1.51% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 391.0k
21 KURA ONCOLOGY INC COM KURA KURA 575,000 $12.0m1.45% 1.45% UnchangedShares held: Q3 2020 575.0k, Q4 2020 575.0k, Q1 2021 575.0k, Q2 2021 575.0k
22 KEROS THERAPEUTICS INC COM KROS KROS 272,306 $11.6m1.40% 1.40% ReducedShares held: Q3 2020 672.3k, Q4 2020 672.3k, Q1 2021 372.3k, Q2 2021 272.3k -100.0k -100,000 -26.9%
23 COGENT BIOSCIENCES INC COM COGT COGT 1,088,817 $8.8m1.07% 1.07% UnchangedShares held: Q3 2020 0, Q4 2020 1.1m, Q1 2021 1.1m, Q2 2021 1.1m
24 ALIGOS THERAPEUTICS INC COM COM 408,377 $8.3m1.01% 1.01% UnchangedShares held: Q3 2020 0, Q4 2020 404.9k, Q1 2021 408.4k, Q2 2021 408.4k
25 AKOYA BIOSCIENCES INC COM AKYA AKYA 400,000 $7.7m0.94% 0.94% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 400.0k
26 HARPOON THERAPEUTICS INC COM COM 512,005 $7.1m0.86% 0.86% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 512.0k
27 CATABASIS PHARMACEUTICALS IN COM NEW CATB CATB 3,234,000 $6.8m0.83% 0.83% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 3.2m
28 ADICET BIO INC COM COM 183,702 $1.9m0.23% 0.23% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.0m, Q2 2021 183.7k -816.3k -816,298 -81.6%
29 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 19,495 $357.0k0.04% 0.04% UnchangedShares held: Q3 2020 0, Q4 2020 19.5k, Q1 2021 19.5k, Q2 2021 19.5k

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
CONSTELLATION PHARMCETICLS I CNST CNST 4,016,873 $94.0m4.0m shares
SYNDAX PHARMACEUTICALS INC SNDX SNDX 591,782 $13.2m591.8k shares
APTOSE BIOSCIENCES INC 1,605,400 $9.6m1.6m shares
EYEPOINT PHARMACEUTICALS INC EYPT EYPT 700,000 $7.1m700.0k shares
BCTG ACQUISITION CORP 500,000 $5.6m500.0k shares
METACRINE INC 680,000 $4.2m680.0k shares
ARS PHARMACEUTICALS INC SPRY SPRY 85,000 $3.7m85.0k shares
TAYSHA GENE THERAPIES INC TSHA TSHA 120,649 $2.4m120.6k shares